VIFN.SW - Vifor Pharma AG

Swiss - Swiss Delayed Price. Currency in CHF
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Total Revenue
1,750,600
1,584,700
1,342,100
4,118,370
3,791,586
Cost of Revenue
733,900
648,700
517,900
2,479,002
2,330,211
Gross Profit
1,016,700
936,000
824,200
1,639,368
1,461,375
Operating Expenses
Research Development
223,900
206,400
185,100
-
-
Selling General and Administrative
575,800
566,700
596,400
280,580
219,694
Total Operating Expenses
755,700
708,500
689,900
1,283,131
1,015,540
Operating Income or Loss
261,000
227,500
134,300
356,237
445,835
Interest Expense
15,900
6,800
25,200
30,669
21,810
Total Other Income/Expenses Net
-
-
-
-
-
Income Before Tax
252,200
269,400
125,600
335,531
428,978
Income Tax Expense
39,800
25,000
1,600
11,766
58,975
Income from Continuing Operations
212,400
244,400
124,000
323,765
370,003
Net Income
99,600
152,400
1,147,100
243,627
301,060
Net Income available to common shareholders
99,600
152,400
1,147,100
243,627
301,060
Reported EPS
Basic
-
2.35
17.70
3.76
4.65
Diluted
-
2.34
17.67
3.76
4.64
Weighted average shares outstanding
Basic
-
64,849
64,810
64,767
64,793
Diluted
-
65,015
64,918
64,867
64,906
EBITDA
-
440,300
296,800
493,771
537,387